These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 15751018)

  • 1. Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients.
    Nishizawa A; Nakanishi Y; Yoshimura K; Sasajima Y; Yamazaki N; Yamamoto A; Hanada K; Kanai Y; Hirohashi S
    Cancer; 2005 Apr; 103(8):1693-700. PubMed ID: 15751018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
    Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
    Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of dysadherin expression in patients with non-small cell lung cancer.
    Tamura M; Ohta Y; Tsunezuka Y; Matsumoto I; Kawakami K; Oda M; Watanabe G
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):740-5. PubMed ID: 16153922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of dysadherin and cytokeratin as prognostic indicators of disease-free survival in patients with stage I NSCLC.
    Ono K; Uramoto H; Hanagiri T
    Anticancer Res; 2010 Sep; 30(9):3273-8. PubMed ID: 20944097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of dysadherin and E-cadherin expression in differentiated-type gastric carcinoma with submucosal invasion.
    Maehata Y; Hirahashi M; Aishima S; Kishimoto J; Hirohashi S; Yao T; Takashima H; Tsuneyoshi M; Oda Y
    Hum Pathol; 2011 Apr; 42(4):558-67. PubMed ID: 21239043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of dysadherin expression in advanced colorectal carcinoma.
    Aoki S; Shimamura T; Shibata T; Nakanishi Y; Moriya Y; Sato Y; Kitajima M; Sakamoto M; Hirohashi S
    Br J Cancer; 2003 Mar; 88(5):726-32. PubMed ID: 12618882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of dysadherin and E-cadherin expression in patients with head and neck cancer treated by radiation therapy.
    Muramatsu H; Akimoto T; Maebayashi K; Kita M; Mitsuhashi N
    Anticancer Res; 2008; 28(6B):3859-64. PubMed ID: 19192641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of dysadherin expression in esophageal squamous cell carcinoma.
    Shimada Y; Hashimoto Y; Kan T; Kawamura J; Okumura T; Soma T; Kondo K; Teratani N; Watanabe G; Ino Y; Sakamoto M; Hirohashi S; Imamura M
    Oncology; 2004; 67(1):73-80. PubMed ID: 15459499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer.
    Zhong XY; Zhang LH; Jia SQ; Shi T; Niu ZJ; Du H; Zhang GG; Hu Y; Lu AP; Li JY; Ji JF
    Histopathology; 2008 Apr; 52(5):560-8. PubMed ID: 18312357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of dysadherin expression in tongue cancer: immunohistochemical analysis of 91 cases.
    Nakanishi Y; Akimoto S; Sato Y; Kanai Y; Sakamoto M; Hirohashi S
    Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):323-8. PubMed ID: 15536331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays.
    Bauer R; Wild PJ; Meyer S; Bataille F; Pauer A; Klinkhammer-Schalke M; Hofstaedter F; Bosserhoff AK
    J Clin Pathol; 2006 Jul; 59(7):699-705. PubMed ID: 16565225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant O-glycosylation inhibits stable expression of dysadherin, a carcinoma-associated antigen, and facilitates cell-cell adhesion.
    Tsuiji H; Takasaki S; Sakamoto M; Irimura T; Hirohashi S
    Glycobiology; 2003 Jul; 13(7):521-7. PubMed ID: 12672699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
    Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) expression in relation to cadherin expression in patients with colorectal carcinoma.
    Tsujitani S; Saito H; Honboh T; Ataka M; Tanida T; Makino M; Ikeguchi M
    Dis Colon Rectum; 2007 Aug; 50(8):1241-9. PubMed ID: 17429708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.
    Zhong LP; Li J; Zhang CP; Zhu HG; Sun J; Zhang ZY
    Arch Oral Biol; 2007 Aug; 52(8):740-7. PubMed ID: 17331461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
    Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU
    J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: relationship to e-cadherin expression.
    Shimamura T; Sakamoto M; Ino Y; Sato Y; Shimada K; Kosuge T; Sekihara H; Hirohashi S
    J Clin Oncol; 2003 Feb; 21(4):659-67. PubMed ID: 12586803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer.
    Boo YJ; Park JM; Kim J; Chae YS; Min BW; Um JW; Moon HY
    Ann Surg Oncol; 2007 May; 14(5):1703-11. PubMed ID: 17211730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-cadherin and beta-catenin expression patterns in malignant melanoma assessed by image analysis.
    Pećina-Slaus N; Zigmund M; Kusec V; Martić TN; Cacić M; Slaus M
    J Cutan Pathol; 2007 Mar; 34(3):239-46. PubMed ID: 17302608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma.
    Piras F; Murtas D; Minerba L; Ugalde J; Floris C; Maxia C; Colombari R; Perra MT; Sirigu P
    Histopathology; 2007 Jun; 50(7):835-42. PubMed ID: 17543072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.